Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab in Postmenopausal Chinese Women With Osteoporosis
NCT05067335Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2021
- Primary completion
- Nov 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of romosozumab in osteoporosis, sponsored by UCB. Started Oct 2021; status: completed.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05067335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05067335.